Physician profile
Monica A Walker
NPI 1003950551
$5,342.60
in general payments reported to CMS, 2019-2025
31 companies · $1,053 in 2025
The $1,053 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,465 · 2020: $448 · 2021: $375 · 2022: $724 · 2023: $606 · 2024: $671 · 2025: $1,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,284 · Education: $45.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,284.37 |
| Education | $45.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $836.31 | 2019-2025 | Airsupra, Breztri |
| Lilly USA, LLC | $573.28 | 2019-2025 | Zepbound, Jardiance, Mounjaro |
| Novo Nordisk INC | $499.48 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $434.43 | 2019-2024 | |
| Vanda Pharmaceuticals INC. | $373.78 | 2019-2023 | Hetlioz, Fanapt |
| Paratek Pharmaceuticals, INC. | $364.73 | 2023-2025 | Nuzyra, Xhance |
| Atricure, INC. | $271.53 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $234.52 | 2022-2025 | Jardiance, Synjardy |
| Ani Pharmaceuticals, INC. | $199.52 | 2025 | Purified Cortrophin Gel |
| Amarin Pharma, INC. | $197.03 | 2019-2020 | |
| Glaxosmithkline, LLC. | $165.78 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Silk Road Medical, INC. | $151.52 | 2019 | |
| Amgen INC. | $138.33 | 2023-2025 | Repatha, Otezla, Repatha |
| Abbott Laboratories | $107.53 | 2023-2025 | Freestyle Libre 3 |
| Edwards Lifesciences Corporation | $105.38 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $100.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $81.88 | 2019-2020 | |
| Ethicon US, LLC | $74.67 | 2019 | |
| Arbor Pharmaceuticals, INC. | $65.11 | 2019-2021 | |
| Redhill Biopharma INC. | $64.69 | 2020 | |
| Dexcom, INC. | $61.11 | 2021-2025 | Dexcom G6 Transmitter |
| Kowa Pharmaceuticals America, INC. | $42.37 | 2023-2025 | Zoryve, Seglentis |
| Exact Sciences Corporation | $32.81 | 2025 | The Cologuard Plus Collection Kit |
| Amneal Pharmaceuticals LLC | $28.63 | 2023 | Lyvispah |
| Abbvie INC. | $25.07 | 2021 | |
| Xeris Pharmaceuticals, INC. | $22.92 | 2025 | Gvoke Hypopen |
| Ibsa Pharma INC. | $22.78 | 2022 | |
| Organogenesis INC. | $20.22 | 2024 | |
| Allergan, INC. | $16.27 | 2019 | |
| Scilex Pharmaceuticals INC. | $15.55 | 2023 | Ztlido |
| Sanofi-Aventis U.S. LLC | $15.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.